Edwards Lifesciences Corporation EW
86.29
0.56
0.65%
as of 25 Sep
- Market cap
- $49.4B
- P/E
- 49.6×
Follow EW
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Edwards Lifesciences Corporation (EW) Revenue growth
Edwards Lifesciences Corporation's revenue growth over the twelve months to 30 June 2026 was 14.6%, up 3.0 percentage points from fiscal 2025 (11.6%). Over the past ten years it has ranged from −14.7% (fiscal 2022) to 19.3% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Devices industry median of 8.80% and above the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 11.6% | 2.98 |
| FY2024 | 8.57% | (3.66) |
| FY2023 | 12.2% | 26.92 |
| FY2022 | −14.7% | (33.98) |
| FY2021 | 19.3% | 18.41 |
| FY2020 | 0.88% | (15.91) |
| FY2019 | 16.8% | 8.42 |
| FY2018 | 8.37% | (7.54) |
| FY2017 | 15.9% | (2.94) |
| FY2016 | 18.9% | 11.50 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 13.6% | (3.07) |
| Mar 2026 | 16.7% | 3.44 |
| Dec 2025 | 13.3% | (1.41) |
| Sep 2025 | 14.7% | 2.78 |
| 42 more quarters | Free account |
Against its own ten years
Low −14.7%
High 19.3%
Ten-year median
11.6%
Current reading's percentile
55
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| DXCM DexCom, Inc. compare | 15.5% |
| EW Edwards Lifesciences Corporation | 14.6% |
| BSX Boston Scientific Corporation compare | 13.5% |
| MDT Medtronic PLC compare | 9.77% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 8.62% |
| SYK Stryker Corporation compare | 8.48% |
| STE STERIS plc compare | 8.37% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on EW
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement